192 related articles for article (PubMed ID: 24978354)
1. Perioperative complications after neoadjuvant chemotherapy and radical cystectomy for bladder cancer.
Tyson MD; Bryce AH; Ho TH; Carballido EM; Castle EP
Can J Urol; 2014 Jun; 21(3):7259-65. PubMed ID: 24978354
[TBL] [Abstract][Full Text] [Related]
2. The effect of neoadjuvant chemotherapy on perioperative outcomes in patients who have bladder cancer treated with radical cystectomy: a population-based study.
Gandaglia G; Popa I; Abdollah F; Schiffmann J; Shariat SF; Briganti A; Montorsi F; Trinh QD; Karakiewicz PI; Sun M
Eur Urol; 2014 Sep; 66(3):561-8. PubMed ID: 24486024
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity.
Johnson DC; Nielsen ME; Matthews J; Woods ME; Wallen EM; Pruthi RS; Milowsky MI; Smith AB
BJU Int; 2014 Aug; 114(2):221-8. PubMed ID: 24274722
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant Chemotherapy Does Not Increase the Morbidity of Radical Cystectomy: A 10-year Retrospective Nationwide Study.
Salminen AP; Koskinen I; Perez IM; Hurme S; Murtola TJ; Vaarala MH; Nykopp TK; Seppänen M; Isotalo T; Marttila T; Levomäki L; Becker S; Anttinen M; Liukkonen T; Säily M; Pogodin-Hannolainen D; Viitanen J; Palmberg C; Ottelin J; Sairanen J; Ettala OO; Boström PJ
Eur Urol Oncol; 2018 Dec; 1(6):525-530. PubMed ID: 31158099
[TBL] [Abstract][Full Text] [Related]
5. Impact of suboptimal neoadjuvant chemotherapy on peri-operative outcomes and survival after robot-assisted radical cystectomy: a multicentre multinational study.
Hinata N; Hussein AA; George S; Trump DL; Levine EG; Omar K; Dasgupta P; Khan MS; Hosseini A; Wiklund P; Guru KA
BJU Int; 2017 Apr; 119(4):605-611. PubMed ID: 27743481
[TBL] [Abstract][Full Text] [Related]
6. Impact of neoadjuvant chemotherapy on short-term complications and survival following radical cystectomy.
Milenkovic U; Akand M; Moris L; Demaegd L; Muilwijk T; Bekhuis Y; Laenen A; Van Cleynenbreugel B; Everaerts W; Van Poppel H; Dumez H; Albersen M; Joniau S
World J Urol; 2019 Sep; 37(9):1857-1866. PubMed ID: 30519746
[TBL] [Abstract][Full Text] [Related]
7. Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical Cystectomy.
Chalfin HJ; Liu JJ; Gandhi N; Feng Z; Johnson D; Netto GJ; Drake CG; Hahn NM; Schoenberg MP; Trock BJ; Scott AV; Frank SM; Bivalacqua TJ
Ann Surg Oncol; 2016 Aug; 23(8):2715-22. PubMed ID: 27012987
[TBL] [Abstract][Full Text] [Related]
8. Comparative Perioperative Outcomes in Septuagenarians and Octogenarians Undergoing Radical Cystectomy for Bladder Cancer-Do Outcomes Differ?
Haden TD; Prunty MC; Jones AB; Deroche CB; Murray KS; Pokala N
Eur Urol Focus; 2018 Dec; 4(6):895-899. PubMed ID: 28865996
[TBL] [Abstract][Full Text] [Related]
9. Determining the optimal time for radical cystectomy after neoadjuvant chemotherapy.
Mmeje CO; Benson CR; Nogueras-González GM; Jayaratna IS; Gao J; Siefker-Radtke AO; Kamat AM; Dinney CP; Navai N; Shah JB
BJU Int; 2018 Jul; 122(1):89-98. PubMed ID: 29569824
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant Chemotherapy is Not Associated with Adverse Perioperative Outcomes after Robot-Assisted Radical Cystectomy: A Case for Increased Use from the IRCC.
Aldhaam NA; Elsayed AS; Jing Z; Richstone L; Wagner AA; Rha KH; Yuh B; Palou J; Khan MS; Menon M; Roupret M; Balbay D; Hosseini A; Wiklund P; Gaboardi F; Maatman TJ; Mottrie A; Wijburg C; Stöckle M; Hemal A; Kim E; Kaouk J; Hussein AA; Guru KA
J Urol; 2020 Jan; 203(1):57-61. PubMed ID: 31600114
[TBL] [Abstract][Full Text] [Related]
11. The current status of perioperative chemotherapy for invasive bladder cancer: a multiinstitutional retrospective study in Japan.
Matsui Y; Nishiyama H; Watanabe J; Teramukai S; Ono Y; Ohshima S; Fujimoto K; Hirao Y; Fukushima M; Ogawa O
Int J Clin Oncol; 2005 Apr; 10(2):133-8. PubMed ID: 15864700
[TBL] [Abstract][Full Text] [Related]
12. Morbidity and mortality of octogenarians following open radical cystectomy using a standardized reporting system.
Berneking AD; Rosevear HM; Askeland EJ; Newton MR; O'Donnell MA; Brown JA
Can J Urol; 2013 Aug; 20(4):6826-31. PubMed ID: 23930606
[TBL] [Abstract][Full Text] [Related]
13. Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer: a multidisciplinary approach.
Alva AS; Tallman CT; He C; Hussain MH; Hafez K; Montie JE; Smith DC; Weizer AZ; Wood D; Lee CT
Cancer; 2012 Jan; 118(1):44-53. PubMed ID: 21598245
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of cystoscopy findings following neoadjuvant chemotherapy for muscle-invasive bladder cancer.
Mansour AM; Soloway MS; Eldefrawy A; Singal R; Joshi S; Manoharan M
Can J Urol; 2015 Apr; 22(2):7690-7. PubMed ID: 25891331
[TBL] [Abstract][Full Text] [Related]
15. Urinary bladder cancer treated with radical cystectomy: perioperative parameters and early complications prospectively registered in a national population-based database.
Jerlström T; Gårdmark T; Carringer M; Holmäng S; Liedberg F; Hosseini A; Malmström PU; Ljungberg B; Hagberg O; Jahnson S
Scand J Urol; 2014 Aug; 48(4):334-40. PubMed ID: 24844275
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2-T4aN0-N2M0 bladder cancer.
Wosnitzer MS; Hruby GW; Murphy AM; Barlow LJ; Cordon-Cardo C; Mansukhani M; Petrylak DP; Benson MC; McKiernan JM
Cancer; 2012 Jan; 118(2):358-64. PubMed ID: 21717438
[TBL] [Abstract][Full Text] [Related]
17. Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomy.
Zareba P; Patterson L; Pandya R; Margel D; Hotte SJ; Mukherjee SD; Elavathil L; Daya D; Shayegan B; Pinthus JH
Urol Oncol; 2014 Oct; 32(7):975-80. PubMed ID: 25027682
[TBL] [Abstract][Full Text] [Related]
18. Underutilization of immediate intravesical chemotherapy following TURBT: results from NSQIP.
Kowalik C; Gee JR; Sorcini A; Moinzadeh A; Canes D
Can J Urol; 2014 Jun; 21(3):7266-70. PubMed ID: 24978355
[TBL] [Abstract][Full Text] [Related]
19. Surgical factors influence bladder cancer outcomes: a cooperative group report.
Herr HW; Faulkner JR; Grossman HB; Natale RB; deVere White R; Sarosdy MF; Crawford ED
J Clin Oncol; 2004 Jul; 22(14):2781-9. PubMed ID: 15199091
[TBL] [Abstract][Full Text] [Related]
20. Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer.
Rosenblatt R; Sherif A; Rintala E; Wahlqvist R; Ullén A; Nilsson S; Malmström PU;
Eur Urol; 2012 Jun; 61(6):1229-38. PubMed ID: 22189383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
